BCDA
BioCardia, Inc.
BioCardia, Inc. (BCDA) has 15 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 15, 2026.
The most active filer is President and CEO Altman Peter with 11 filings. Insiders have net bought $142K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Peter A. Altman
- Employees:17
- HQ:Sunnyvale, CA, US
- IPO:1996-11-13
Insider Buying
$142K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$9.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| President and CEO | Purchase | 2,800 | $2K | Jul 15 | SEC ↗ | |
| President and CEO | Purchase | 1,500 | $1K | Jul 15 | SEC ↗ | |
| President and CEO | Purchase | 10,900 | $11K | Jul 10 | SEC ↗ | |
| President and CEO | Purchase | 1,000 | $900 | Jul 10 | SEC ↗ | |
| President and CEO | Purchase | 1,000 | $940 | Jul 10 | SEC ↗ | |
STERTZER SIMON HFirst filing | Director | Purchase | 70,200 | $65K | Jun 24 | SEC ↗ |
STERTZER SIMON HFirst filing | Director | Purchase | 39,000 | $39K | Jun 24 | SEC ↗ |
| President and CEO | Purchase | 1,500 | $1K | Jun 22 | SEC ↗ | |
| President and CEO | Purchase | 800 | $768 | Jun 22 | SEC ↗ | |
| President and CEO | Purchase | 5,000 | $4K | Jun 9 | SEC ↗ | |
| President and CEO | Purchase | 5,700 | $5K | May 19 | SEC ↗ | |
| President and CEO | Purchase | 5,100 | $5K | May 15 | SEC ↗ | |
Altman PeterFirst filing | President and CEO | Purchase | 5,000 | $6K | Apr 29 | SEC ↗ |
Related companies
BioCardia, Inc. is in the Healthcare sector.